Fwd: Discover the benefits of publishing Open Access with us
Tuyet Lan Le Thi
From: World Allergy Organization Journal <STMJo...@author.email.elsevier.com>
Date: Wed, May 25, 2022 at 5:27 PM
Subject: Discover the benefits of publishing Open Access with us
To: <tuyet...@gmail.com>
|
If you are unable to view this message correctly, click here |
|
|
|
Achieve high impact for your next open access paper
Dear Le Thi Tuyet Lan, You previously chose to publish your work with Elsevier, for which we thank you. We now invite you to consider publishing in our open access title, World Allergy Organization Journal. With a CiteScore of 4.7, World Allergy Organization Journal will allow you to share your work in an established open access journal that publishes top quality, original research in your field, with the benefits of rigorous peer review. Your research will also achieve high visibility – published articles are featured on ScienceDirect, the world’s leading research platform with more than 7 million unique visitors each week. We attach some articles from World Allergy Organization Journal that you might enjoy reading. |
The World Allergy Organization Journal is the official journal of the World Allergy Organization, publishing original research, clinical reviews, guidelines, position papers, and epidemiological studies that contribute to current knowledge in patient care and providing a global perspective in the fields of allergy, asthma and clinical immunology. Five Year Impact Factor: 4.942
|
|
Read some of the articles we published in your field over the past 18 months: |
| Would you like to explore more journals that could be suitable for the publication of your work? Visit JournalFinder. |
|
Official journal of World Allergy Organization World Allergy Organization Journal is a peer reviewed, open access journal with no subscription charges, therefore a fee is payable by the author, or their institution or funder to cover the publication costs. This ensures your article will be immediately, permanently and freely available for anyone to access, read and build on. CiteScore™ is powered by Scopus®. Journal Impact Factor as stated in Journal Citation Reports® (Clarivate Analytics, 2021). Can we assist you with something? Visit our help page » |
|
| Was the journal we recommended relevant for your next submission? |
|
Chairwoman, Hochiminh city Asthma, Allergy and Clinical Immunology Society.
UMC, University of Medicine and Pharmacy
217 Hongbang, Dist 5
Hochiminh city , Vietnam